| 12428397 |
Factor XI activation inhibitors |
Jacqueline D. Hicks, John S. Debenham, Amjad Ali, Ying-Duo Gao, Dexi Yang +4 more |
2025-09-30 |
|
| 12312332 |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists |
Stephane L. Bogen, Ping Chen, Dane Clausen, Jinsong Hao, Dipannita Kalyani +3 more |
2025-05-27 |
|
| 12304899 |
Factor XI activation inhibitors |
Jacqueline D. Hicks, John S. Debenham, Amjad Ali, Tianying Jian, Dexi Yang +11 more |
2025-05-20 |
|
| 11680060 |
Bicycloheptane pyrrolidine orexin receptor agonists |
Stephane L. Bogen, Dane Clausen, Deodial Guy Guiadeen, Jinsong Hao, Shishi Lin +3 more |
2023-06-20 |
$1,826,626,000 |
| 9868733 |
Azabenzimidazole tetrahydrofuran derivatives |
James M. Apgar, Tesfaye Biftu, Ping Chen, Danqing Feng, Jacqueline D. Hicks +8 more |
2018-01-16 |
$61,578,000 |
| 9556193 |
Benzimidazole hexahydrofuro[3,2-b]furan derivatives |
James M. Apgar, Ashok Arasappan, Tesfaye Biftu, Ping Chen, Danqing Feng +9 more |
2017-01-31 |
|
| 9540364 |
Benzimidazole tetrahydrofuran derivatives |
James M. Apgar, Tesfaye Biftu, Ping Chen, Danqing Feng, Jacqueline D. Hicks +7 more |
2017-01-10 |
$109,765,000 |
| 9527839 |
Benzimidazole tetrahydropyran derivatives |
James M. Apgar, Tesfaye Biftu, Ping Chen, Danqing Feng, Jacqueline D. Hicks +7 more |
2016-12-27 |
$78,520,000 |
| 9382243 |
Azabenzimidazole tetrahydropyran derivatives |
James M. Apgar, Tesfaye Biftu, Ping Chen, Danqing Feng, Jacqueline D. Hicks +7 more |
2016-07-05 |
$61,670,000 |
| 9290517 |
Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives |
James M. Apgar, Ashok Arasappan, Tesfaye Biftu, Ping Chen, Danqing Feng +10 more |
2016-03-22 |
$71,894,000 |
| 9029377 |
Platelet-activating factor receptor antagonists |
Anthony Ogawa, Feroze Ujjainwalla, Lin Chu, Bing Li, Jinyou Xu +3 more |
2015-05-12 |
$67,061,000 |
| 8853212 |
Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes |
Robert R. Wilkening, James M. Apgar, Tesfaye Biftu, Danqing Feng, Xiaoxia Qian |
2014-10-07 |
$95,795,000 |
| 8796258 |
Cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
Rajan Anand, James M. Apgar, Tesfaye Biftu, Ping Chen, Lin Chu +13 more |
2014-08-05 |
$53,413,000 |
| 7687492 |
1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Jinyou Xu, Anthony Mastracchio, Scott D. Edmondson |
2010-03-30 |
$119,966,000 |
